Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy

ClinicalTrials.gov · TERMINATED, 2016

175 participants

Abstract

The aim of this study is to determine whether antibiotics prophylaxis at the time of urinary catheter removal decreases the number of symptomatic urinary tract infections in patients after radical prostatectomy. In addition, the investigators aim to determine whether antibiotic prophylaxis is potentially harmful to patients (e.g. adverse reactions from antibiotic use, resistant bacteria in the urine, Clostridium difficile infections etc.). The investigators also aim to identify specific populations that may be at higher risk of developing urinary tract infections with urinary catheter use after radical prostatectomy.

Conditions: Prostate Cancer, Urinary Tract Infection, Clostridium Difficile.

Primary outcome: Number of Participants With a Positive Urinary Tract Infection.

Enrollment: 175 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 175 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

• ClinicalTrials.gov
• Publisher page

Related studies

• Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes Infection and Drug Resistance, 2014
• Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli Molecular Biology and Evolution, 2017
• Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms Frontiers in Microbiology, 2020
• Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18 Journal of Antimicrobial Chemotherapy, 2019
• Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli Journal of Antimicrobial Chemotherapy, 2017
• Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review Frontiers in Cellular and Infection Microbiology, 2023

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free